MDRX News and Press, Allscripts Healthcare Solutions Inc. From 05/05/20

Allscripts Healthcare Solutions, Inc. (Nasdaq: MDRX) today announced that, due to the public health impact of the novel coronavirus (COVID-19) pandemic, related governmental actions and the importance of safeguarding the health of its stockholders, employees and representatives, Allscripts wi...

Designed and created for health systems to dynamically forecast and plan for local market COVID-19 conditions leveraging national, state, and county level data along with advanced analytic techniques. EPSi, Allscripts’ (NASDAQ: MDRX) flagship budgeting, planning/forecasting, cos...

Veradigm is working daily to help defeat COVID-19; supporting providers on the front line with tools to better manage their patients as well as arming researchers with patient data to enable a better understanding of virus patterns, symptoms, treatments and outcomes As a leading provid...

Allscripts Healthcare Solutions, Inc . (Nasdaq:MDRX) will report its financial results for the three months ended March 31, 2020 after the close of stock market hours on Thursday, May 7, 2020. Allscripts management plans to host a conference call and webcast to discuss the company's earnings...

Allscripts Healthcare Solutions (NASDAQ: MDRX ) initiated with Outperform rating and $8 (21% upside) price target at RBC. More news on: Allscripts Healthcare Solutions, Inc., Aprea Therapeutics, Inc., Avita Medical Limited, Healthcare stocks news, Stocks on the move, , Read more ...

New York City, NY: April 16, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of e-Prescription Systems Market in Global Industry: 2020 Research and New Innovations in Technology and Media Sector. The prime objective of the report is to offer upd...

New York City, NY: April 16, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Electronic Health Records Market in Global Industry: 2020 Research and New Innovations in Technology and Media Sector. The prime objective of the report is to offer ...

Allogene Therapeutics (NASDAQ: ALLO ) initiated with Buy rating and $29 (28% upside) price target at SunTrust. More news on: Allogene Therapeutics, Inc., BridgeBio Pharma, Inc., Cerner Corporation, Healthcare stocks news, Stocks on the move, , Read more ...

Company offers streamlined telehealth implementation to health systems through its EHR-agnostic patient engagement platform, Allscripts FollowMyHealth®, amid COVID-19 Allscripts (NASDAQ: MDRX) clients across the nation have signed up to deliver telehealth visit capabilities in a q...

Launches industry resource providing current learnings, latest trends and best practices from 1,000 hospitals and 180,000 post-acute providers are now available through CarePort’s COVID-19 Transitions of Care Hub CarePort Health , a wholly-owned subsidiary of Allscripts (NASDAQ...